News

Latest news

Hide mandatory notifications of trade

Mandatory Notification of trade

Oslo, 15.06.2012 - CEO of Bionor Pharma ASA, Steen Krøyer, has yesterday, as part of the Company's Private Placement, purchased 117,200 Bionor shares at a price of NOK 3.20 per share.

The shares are held through a nominee account in Nordea Luxembourg. Steen Krøyer's holding after the purchase is 267,200 Bionor shares. This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act).